ITGAM and breast cancer: However, in Chinese BC patients, we did not observe a significant difference in CD15 expression in myeloid cells, and we identified CD11b+CD33lowHLA-DR− CD3− as the markers for MDSCs, which are significantly increased in BC patients at stages of T2-T4.